Hepion Pharmaceuticals, Inc.
HEPA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583771
In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 6 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Other share classesCTRVP
Q3 2021 vs. Q2 2021
How the institutions holding Hepion Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 49 | 1 | 42 | −6 |
| Shares | 10.8M | 10.0K | 7.80M | −2.96M (−27.5%) |
| Value | $21.3M | $20.0K | $11.9M | −$9.34M (−43.9%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Hepion Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| The PNC Financial Services Group, Inc. | 39,034 | $60.0K | 0.00% |
| Qube Research & Technologies Ltd | 16,279 | $25.0K | 0.00% |
| Fort Point Capital Partners LLC | 10,000 | $15.0K | 0.00% |
| Migdal Insurance & Financial Holdings Ltd. | 2,607 | $4.00K | 0.00% |
| US Bancorp | 1,000 | $2.00K | 0.00% |
Sold out (11)
Institutions that held Hepion Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Altium Capital Management LP | 446,000 | $883.0K |
| Two Sigma Investments, LP | 245,007 | $485.0K |
| Virtu Financial LLC | 113,869 | $225.0K |
| Meitav Dash Investments Ltd | 50,000 | $99.0K |
| Zeke Capital Advisors, LLC | 50,000 | $99.0K |
| Moloney Securities Asset Management, LLC | 27,340 | $54.0K |
| Allen Capital Group, LLC | 23,685 | $47.0K |
| Jane Street Group, LLC | 18,328 | $36.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 13,131 | $26.0K |
| Tower Research Capital LLC (TRC) | 3,418 | $7.00K |
| Prentice Wealth Management LLC | 250 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Hepion Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| San Francisco Sentry Investment Group (Ca) | 10,000 | $20.0K |